Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Lacidipine and Telmisartan FDC vs Separate Tablets
NCT02209649Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 1999
- Primary completion
- Dec 1999
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of lacidipine and telmisartan in hypertension (HTN) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the curve at steady state at Day 7, Maximum concentration at steady state at Day 7 and 11 more. Started Oct 1999; status: completed.
02
Drugs
lacidipinetelmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02209649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02209649.